With 253,834 studies located in 200 countries, ensuring smooth and cost-effective global clinical trial supply has become a standard for the pharmaceutical industry. Experts from all regions have answered our survey on the main pain points they face, how they can improve their supply chain and what drives its success. Anat Batsri, Global Clinical Supply Chain Study Lead at OPKO Biologics, had a look at the results and gave us her feedback on what the results showed.
New labelling requirements: How is the clinical trial supply industry getting ready to stay compliant?
The new Clinical Trials Regulation is to be enforced in 2019 and the clinical trial supply industry is preparing now to remain compliant and companies will have to change their labelling process in order to save costs and stay up to date with the requirements.
In this exclusive article, we have surveyed more than 250 clinical trial supply experts from all around the world to gain insight on where their investment priorities lie in terms of labelling solutions and what their time frame is, in order to better understand how their industry is getting ready to comply with the new legislation.
Improving clinical trial supply through innovative supply chain platforms: Challenges and opportunities
Clinical trials are on the rise and new designs such as adaptive clinical trials are emerging, requiring flexibility and transparency and forcing pharma companies to re-assess their approach to their supply chain to adapt to these changes. Ahead of the Clinical Trial Supply Forum, we sat down with one of the speakers, Antony Pham, Co-founder of consulting and tech-based SPLY ApS to discuss the opportunities and challenges associated with the implementation of new technologies in the supply chain and how they can increase the companies' efficiency while reducing costs.